AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
20:17
The Corvin Castle in Hunedoara is undergoing its first complete restoration since 1914, with European funds.
19:54
Romania reported the highest number of suspected fraud cases regarding EU spending
19:37
The USA signed a 3 billion dollar agreement in the production of Patriot and THAAD missiles.
19:17
The PSD-AUR amendment that targets Dominic Fritz, compared by Cătălin Drulă to Emergency Ordinance 13 and the risk of 800 million euros from the PNRR.
19:00
Flavia Boghiu, former USR vice mayor of Brașov, definitively acquitted in the "Catacombs" case.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
